Astrocytes derived from trisomic human embryonic stem cells express markers of astrocytic cancer cells and premalignant stem-like progenitors

BMC Medical Genomics

Volumn 3, Issue , 2010, Pages

  Gopalakrishna Pillai, Sailesh ^a   Iverson, Linda E ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA; TUMOR MARKER;

ANEUPLOIDY; ANIMAL CELL; ARTICLE; ASTROCYTE; ASTROCYTOMA; BIOINFORMATICS; CANCER CELL CULTURE; CANCER STEM CELL; CONTROLLED STUDY; DIPLOIDY; EMBRYO; EMBRYONIC STEM CELL; EXON; GENE EXPRESSION PROFILING; GENETIC MARKER; GENETIC TRANSCRIPTION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TRISOMY; ALTERNATIVE RNA SPLICING; BIOLOGY; CELL DIFFERENTIATION; CELL LINE; CYTOLOGY; GENETICS; KARYOTYPING; METABOLISM; PRECANCER;

ALTERNATIVE SPLICING; ASTROCYTES; BASE SEQUENCE; CELL DIFFERENTIATION; CELL LINE; COMPUTATIONAL BIOLOGY; EMBRYONIC STEM CELLS; GENE EXPRESSION PROFILING; GLIOBLASTOMA; HUMANS; KARYOTYPING; NEOPLASTIC STEM CELLS; PRECANCEROUS CONDITIONS; TRISOMY; TUMOR MARKERS, BIOLOGICAL;

EID: 77951238605     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-3-12     Document Type: Article

References (50)

1. Therapeutic potential of embryonic stem cells. PH Lerou GQ Daley, Blood Rev 2005 19 6 321 31 10.1016/j.blre.2005.01.005 16275420
2. Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. JS Draper, et al. Nat Biotechnol 2004 22 1 53 4 10.1038/nbt922 14661028
3. CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells. D Herszfeld, et al. Nat Biotechnol 2006 24 3 351 7 10.1038/nbt1197 16501577
4. Characterization of a new NIH-registered variant human embryonic stem cell line, BG01V: a tool for human embryonic stem cell research. TW Plaia, et al. Stem Cells 2006 24 3 531 46 10.1634/stemcells.2005-0315 16293579
5. Stem cells, cancer, and cancer stem cells. T Reya, et al. Nature 2001 414 6859 105 11 10.1038/35102167 11689955
6. Characterization of human embryonic stem cells with features of neoplastic progression. TE Werbowetski-Ogilvie, et al. Nat Biotechnol 2009 27 1 91 7 10.1038/nbt.1516 19122652
7. Preserving the genetic integrity of human embryonic stem cells. MM Mitalipova, et al. Nat Biotechnol 2005 23 1 19 20 10.1038/nbt0105-19 15637610
8. Identification of differentially regulated splice variants and novel exons in glial brain tumors using exon expression arrays. PJ French, et al. Cancer Res 2007 67 12 5635 42 10.1158/0008-5472.CAN-06-2869 17575129
9. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. KJ Livak TD Schmittgen, Methods 2001 25 4 402 8 10.1006/meth.2001.1262 11846609
10. Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme. CT Kuan, et al. Clin Cancer Res 2006 12 7 Pt 1 1970 82 10.1158/1078-0432.CCR-05-2797 16609006
11. The Cancer Genome Atlas (TCGA), Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008 455 7216 1061 8 10.1038/nature07385 18772890
12. Differential expression of HOX genes in neoplastic and non-neoplastic human astrocytes. R Abdel-Fattah, et al. J Pathol 2006 209 1 15 24 10.1002/path.1939 16463268
13. Butyric acid prodrugs are histone deacetylase inhibitors that show antineoplastic activity and radiosensitizing capacity in the treatment of malignant gliomas. M Entin-Meer, et al. Mol Cancer Ther 2005 4 12 1952 61 10.1158/1535-7163.MCT-05-0087 16373710
14. The expression of thyroid hormone receptor isoforms in human astrocytomas. SL Hwang, et al. Surg Neurol 2008 70 S1 4 8 10.1016/j.surneu.2008. 03.033
15. Immunohistochemical localization of apolipoprotein E in human glial neoplasms. M Murakami, et al. J Clin Invest 1988 82 1 177 88 10.1172/JCI113568 3392206
16. Heat shock protein 70 is required for the survival of cancer cells. J Nylandsted K Brand M Jaattela, Ann N Y Acad Sci 2000 926 122 5 11193027
17. Members of the heat-shock protein 70 family promote cancer cell growth by distinct mechanisms. M Rohde, et al. Genes Dev 2005 19 5 570 82 10.1101/gad.305405 15741319
18. Expression of oligodendroglial and astrocytic lineage markers in diffuse gliomas: use of YKL-40, ApoE, ASCL1, and NKX2-2. A Rousseau, et al. J Neuropathol Exp Neurol 2006 65 12 1149 56 10.1097/01.jnen.0000248543.90304.2b 17146289
19. Inhibition of angiogenesis in human glioma cell lines by antisense RNA from the soluble guanylate cyclase genes, GUCY1A3 and GUCY1B3. M Saino, et al. Oncol Rep 2004 12 1 47 52 15201957
20. Expression and the role of cathepsin H in human glioma progression and invasion. M Sivaparvathi, et al. Cancer Lett 1996 104 1 121 6 10.1016/0304-3835(96)04242-5 8640738
21. Spontaneous CD8 T cell responses against the melanocyte differentiation antigen RAB38/NY-MEL-1 in melanoma patients. SM Walton, et al. J Immunol 2006 177 11 8212 8 17114498
22. Transient receptor potential channel activation causes a novel form of [Ca 2+]I oscillations and is not involved in capacitative Ca 2+ entry in glial cells. M Grimaldi M Maratos A Verma, J Neurosci 2003 23 11 4737 45 12805313
23. Truncated tyrosine kinase B brain-derived neurotrophic factor receptor directs cortical neural stem cells to a glial cell fate by a novel signaling mechanism. A Cheng, et al. J Neurochem 2007 100 6 1515 30 17286628
24. Astrocytic control of synaptic NMDA receptors. CJ Lee, et al. J Physiol 2007 581 Pt 3 1057 81 10.1113/jphysiol.2007.130377 17412766
25. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. R Galli, et al. Cancer Res 2004 64 19 7011 21 10.1158/0008-5472.CAN-04-1364 15466194
26. Identification of a cancer stem cell in human brain tumors. SK Singh, et al. Cancer Res 2003 63 18 5821 8 14522905
27. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. HS Phillips, et al. Cancer Cell 2006 9 3 157 73 10.1016/j.ccr.2006.02.019 16530701
28. Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria. HS Gunther, et al. Oncogene 2008 27 20 2897 909 10.1038/sj.onc.1210949 18037961
29. CpG island hypermethylation of the DNA repair enzyme methyltransferase predicts response to temozolomide in primary gliomas. MF Paz, et al. Clin Cancer Res 2004 10 15 4933 8 10.1158/1078-0432.CCR-04-0392 15297393
30. Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. A Murat, et al. J Clin Oncol 2008 26 18 3015 24 10.1200/JCO.2007.15.7164 18565887
31. Mitochondrial Bax translocation partially mediates synergistic cytotoxicity between histone deacetylase inhibitors and proteasome inhibitors in glioma cells. C Yu, et al. Neuro Oncol 2008 10 3 309 19 10.1215/15228517-2007- 063 18445700
32. Neural stem cells and the origin of gliomas. N Sanai A Alvarez-Buylla MS Berger, N Engl J Med 2005 353 8 811 22 10.1056/NEJMra043666 16120861
33. Adult human subventricular, subgranular, and subpial zones contain astrocytes with a specialized intermediate filament cytoskeleton. RF Roelofs, et al. Glia 2005 52 4 289 300 10.1002/glia.20243 16001427
34. Donor-Derived Brain Tumor Following Neural Stem Cell Transplantation in an Ataxia Telangiectasia Patient. N Amariglio, et al. PLoS Med 2009 6 2 29 10.1371/journal.pmed.1000029
35. Regulator of G-protein signaling-5 induction in pericytes coincides with active vessel remodeling during neovascularization. M Berger, et al. Blood 2005 105 3 1094 101 10.1182/blood-2004-06-2315 15459006
36. FK506 binding protein mediates glioma cell growth and sensitivity to rapamycin treatment by regulating NF-kappaB signaling pathway. W Jiang, et al. Neoplasia 2008 10 3 235 43 18320068
37. Insulin-like growth factor binding protein 2 promotes glioma development and progression. SM Dunlap, et al. Proc Natl Acad Sci USA 2007 104 28 11736 41 10.1073/pnas.0703145104 17606927
38. BK channels are linked to inositol 1,4,5-triphosphate receptors via lipid rafts: a novel mechanism for coupling [Ca(2+)](i) to ion channel activation. AK Weaver, et al. J Biol Chem 2007 282 43 31558 68 10.1074/jbc.M702866200 17711864
39. Astrotactin provides a receptor system for CNS neuronal migration. G Fishell ME Hatten, Development 1991 113 3 755 65 1821847
40. Cell surface glypicans are low-affinity endostatin receptors. SA Karumanchi, et al. Mol Cell 2001 7 4 811 22 10.1016/S1097-2765(01)00225-8 11336704
41. The hallmarks of cancer. D Hanahan RA Weinberg, Cell 2000 100 1 57 70 10.1016/S0092-8674(00)81683-9 10647931
42. A two-stage theory of carcinogenesis in relation to the age distribution of human cancer. P Armitage R Doll, Br J Cancer 1957 11 2 161 9 13460138
43. Hansemann, Boveri, chromosomes and the gametogenesis-related theories of tumours. LP Bignold BL Coghlan HP Jersmann, Cell Biol Int 2006 30 7 640 4 10.1016/j.cellbi.2006.04.002 16753311
44. Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. R Beroukhim, et al. Proc Natl Acad Sci USA 2007 104 50 20007 12 10.1073/pnas.0710052104 18077431
45. Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities. EA Maher, et al. Cancer Res 2006 66 23 11502 13 10.1158/0008-5472.CAN-06-2072 17114236
46. Origin of pluripotent germ cell tumours: the role of microenvironment during embryonic development. DM Kristensen, et al. Mol Cell Endocrinol 2008 288 1-2 111 8 10.1016/j.mce.2008.02.018 18420341
47. High-resolution genomic and expression analyses of copy number alterations in breast tumors. PM Haverty, et al. Genes Chromosomes Cancer 2008 47 6 530 42 10.1002/gcc.20558 18335499
48. Cancer-causing karyotypes: chromosomal equilibria between destabilizing aneuploidy and stabilizing selection for oncogenic function. L Li, et al. Cancer Genet Cytogenet 2009 188 1 1 25 10.1016/j.cancergencyto.2008.08.016 19061776
49. Aneuploidy: instigator and inhibitor of tumorigenesis. BA Weaver DW Cleveland, Cancer Res 2007 67 21 10103 5 10.1158/0008-5472.CAN-07-2266 17974949
50. Aneuploidy: cells losing their balance. EM Torres BR Williams A Amon, Genetics 2008 179 2 737 46 10.1534/genetics.108.090878 18558649